{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:58:42Z","timestamp":1789441122568,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T00:00:00Z","timestamp":1744416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncol Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s40487-025-00338-2","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T07:22:43Z","timestamp":1744442563000},"page":"447-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical and Dosimetric Predictors of Early Onset Postradiation Hypothyroidism in Patients with Head and Neck Malignancies: A Logistic Regression Analysis"],"prefix":"10.1007","volume":"13","author":[{"given":"Ahmad","family":"Ameri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Azma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayar","family":"Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooya","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Rahnama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Lesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Poshtmahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farahnaz","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Mirsalehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6195-2203","authenticated-orcid":false,"given":"Farzad","family":"Taghizadeh-Hesary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,12]]},"reference":[{"issue":"1","key":"338_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1425","volume":"5","author":"A Ameri","year":"2022","unstructured":"Ameri A, Norouzi S, Sourati A, Azghandi S, Novin K, Taghizadeh-Hesary F. Randomized trial on acute toxicities of weekly vs three-weekly cisplatin-based chemoradiation in head and neck cancer. Cancer Rep. 2022;5(1): e1425. https:\/\/doi.org\/10.1002\/cnr2.1425.","journal-title":"Cancer Rep"},{"issue":"1","key":"338_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12885-023-11061-4","volume":"23","author":"S-H Hu","year":"2023","unstructured":"Hu S-H, Huang M-Y, Chen C-Y, Hsieh H-M. Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan. BMC Cancer. 2023;23(1):567. https:\/\/doi.org\/10.1186\/s12885-023-11061-4.","journal-title":"BMC Cancer"},{"issue":"1","key":"338_CR3","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12967-022-03774-0","volume":"20","author":"Y Li","year":"2022","unstructured":"Li Y, Jiang Y, Qiu B, Sun H, Wang J. Current radiotherapy for recurrent head and neck cancer in the modern era: a state-of-the-art review. J Transl Med. 2022;20(1):566. https:\/\/doi.org\/10.1186\/s12967-022-03774-0.","journal-title":"J Transl Med"},{"issue":"10","key":"338_CR4","doi-asserted-by":"publisher","first-page":"7427","DOI":"10.1007\/s00432-023-04687-1","volume":"149","author":"A Ameri","year":"2023","unstructured":"Ameri A, et al. Sumac-rose water mouthwash versus benzydamine to prevent radiation-induced oral mucositis in head and neck cancers: a phase II randomized trial. J Cancer Res Clin Oncol. 2023;149(10):7427\u201339. https:\/\/doi.org\/10.1007\/s00432-023-04687-1.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"338_CR5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12885-022-09295-9","volume":"22","author":"JT Pruijssen","year":"2022","unstructured":"Pruijssen JT, et al. Long-term cognitive, psychosocial, and neurovascular complications of unilateral head and neck irradiation in young to middle-aged adults. BMC Cancer. 2022;22(1):244. https:\/\/doi.org\/10.1186\/s12885-022-09295-9.","journal-title":"BMC Cancer"},{"key":"338_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.radonc.2021.01.024","volume":"157","author":"L Van Den Bosch","year":"2021","unstructured":"Van Den Bosch L, et al. Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: a new concept for individually optimised treatment. Radiother Oncol. 2021;157:147\u201354. https:\/\/doi.org\/10.1016\/j.radonc.2021.01.024.","journal-title":"Radiother Oncol"},{"issue":"17","key":"338_CR7","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.3390\/cancers15174321","volume":"15","author":"MK Rooney","year":"2023","unstructured":"Rooney MK, et al. Hypothyroidism following radiotherapy for head and neck cancer: a systematic review of the literature and opportunities to improve the therapeutic ratio. Cancers. 2023;15(17):4321. https:\/\/doi.org\/10.3390\/cancers15174321.","journal-title":"Cancers"},{"issue":"5","key":"338_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/ijms18050911","volume":"18","author":"E Albi","year":"2017","unstructured":"Albi E, et al. Radiation and thyroid cancer. Int J Mol Sci. 2017;18(5):911. https:\/\/doi.org\/10.3390\/ijms18050911.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"338_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12905-023-02718-0","volume":"23","author":"E Kollerits","year":"2023","unstructured":"Kollerits E, Zsila \u00c1, Matuszka B. Quality of life, social support, and adherence in female patients with thyroid disorders. BMC Womens Health. 2023;23(1):567. https:\/\/doi.org\/10.1186\/s12905-023-02718-0.","journal-title":"BMC Womens Health"},{"issue":"8","key":"338_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1089\/thy.2017.0063","volume":"27","author":"NMY Journy","year":"2017","unstructured":"Journy NMY, Bernier M-O, Doody MM, Alexander BH, Linet MS, Kitahara CM. Hyperthyroidism, hypothyroidism, and cause-specific mortality in a large cohort of women. Thyroid. 2017;27(8):1001\u201310. https:\/\/doi.org\/10.1089\/thy.2017.0063.","journal-title":"Thyroid"},{"issue":"5","key":"338_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MED.0000000000000003","volume":"20","author":"S Benvenga","year":"2013","unstructured":"Benvenga S. When thyroid hormone replacement is ineffective? Curr Opin Endocrinol Diabetes Obes. 2013;20(5):467\u201377. https:\/\/doi.org\/10.1097\/MED.0000000000000003.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"338_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105378","volume":"120","author":"M-Y Zhu","year":"2021","unstructured":"Zhu M-Y, et al. Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: development of a nomogram based on the equivalent dose. Oral Oncol. 2021;120: 105378. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105378.","journal-title":"Oral Oncol"},{"key":"338_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.551255","volume":"10","author":"L Peng","year":"2020","unstructured":"Peng L, et al. A new model for predicting hypothyroidism after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Front Oncol. 2020;10: 551255. https:\/\/doi.org\/10.3389\/fonc.2020.551255.","journal-title":"Front Oncol"},{"issue":"1","key":"338_CR14","doi-asserted-by":"publisher","first-page":"323","DOI":"10.21873\/anticanres.16815","volume":"44","author":"N Yoshimura","year":"2024","unstructured":"Yoshimura N, et al. Risk factors causing hypothyroidism in patients with head and neck cancer after radiotherapy using SIB\u2013VMAT. Anticancer Res. 2024;44(1):323\u20139. https:\/\/doi.org\/10.21873\/anticanres.16815.","journal-title":"Anticancer Res"},{"key":"338_CR15","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9332","author":"Y Xu","year":"2018","unstructured":"Xu Y, et al. A dosimetric study on radiation-induced hypothyroidism following intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma. Oncol Lett. 2018. https:\/\/doi.org\/10.3892\/ol.2018.9332.","journal-title":"Oncol Lett"},{"issue":"1","key":"338_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","volume":"117","author":"CL Brouwer","year":"2015","unstructured":"Brouwer CL, et al. CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. Radiother Oncol. 2015;117(1):83\u201390. https:\/\/doi.org\/10.1016\/j.radonc.2015.07.041.","journal-title":"Radiother Oncol"},{"issue":"1","key":"338_CR17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12885-018-4348-z","volume":"18","author":"R Luo","year":"2018","unstructured":"Luo R, et al. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients. BMC Cancer. 2018;18(1):575. https:\/\/doi.org\/10.1186\/s12885-018-4348-z.","journal-title":"BMC Cancer"},{"issue":"4","key":"338_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11102-014-0593-6","volume":"18","author":"J Ratnasingam","year":"2015","unstructured":"Ratnasingam J, et al. Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors. Pituitary. 2015;18(4):448\u201355. https:\/\/doi.org\/10.1007\/s11102-014-0593-6.","journal-title":"Pituitary"},{"key":"338_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ctro.2022.01.001","volume":"33","author":"JCH Chow","year":"2022","unstructured":"Chow JCH, et al. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: a systematic review. Clin Transl Radiat Oncol. 2022;33:83\u201392. https:\/\/doi.org\/10.1016\/j.ctro.2022.01.001.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"2","key":"338_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ijrobp.2009.05.018","volume":"77","author":"R Diaz","year":"2010","unstructured":"Diaz R, et al. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol. 2010;77(2):468\u201376. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.05.018.","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"338_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ijrobp.2017.03.007","volume":"98","author":"K Sommat","year":"2017","unstructured":"Sommat K, et al. Thyroid V40 predicts primary hypothyroidism after intensity modulated radiation therapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2017;98(3):574\u201380. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.007.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"338_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s13014-014-0269-4","volume":"9","author":"A Chyan","year":"2014","unstructured":"Chyan A, Chen J, Shugard E, Lambert L, Quivey JM, Yom SS. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy. Radiat Oncol Lond Engl. 2014;9:269. https:\/\/doi.org\/10.1186\/s13014-014-0269-4.","journal-title":"Radiat Oncol Lond Engl"},{"issue":"16","key":"338_CR23","doi-asserted-by":"publisher","first-page":"6887","DOI":"10.1002\/cam4.2574","volume":"8","author":"C-L Huang","year":"2019","unstructured":"Huang C-L, et al. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy\u2014A single-institution study. Cancer Med. 2019;8(16):6887\u201393. https:\/\/doi.org\/10.1002\/cam4.2574.","journal-title":"Cancer Med"},{"issue":"4","key":"338_CR24","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/COC.0000000000000165","volume":"40","author":"S Sachdev","year":"2017","unstructured":"Sachdev S, Refaat T, Bacchus ID, Sathiaseelan V, Mittal BB. Thyroid V50 highly predictive of hypothyroidism in head-and-neck cancer patients treated with intensity-modulated radiotherapy (IMRT). Am J Clin Oncol. 2017;40(4):413\u20137. https:\/\/doi.org\/10.1097\/COC.0000000000000165.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"338_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijrobp.2008.12.033","volume":"74","author":"WFAR Verbakel","year":"2009","unstructured":"Verbakel WFAR, Cuijpers JP, Hoffmans D, Bieker M, Slotman BJ, Senan S. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. Int J Radiat Oncol. 2009;74(1):252\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.12.033.","journal-title":"Int J Radiat Oncol"},{"issue":"6","key":"338_CR26","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3892\/ol.2014.2039","volume":"7","author":"ES Kim","year":"2014","unstructured":"Kim ES, Yeo S-G. Volumetric modulated arc radiotherapy sparing the thyroid gland for early-stage glottic cancer: a dosimetrical analysis. Oncol Lett. 2014;7(6):1987\u201391. https:\/\/doi.org\/10.3892\/ol.2014.2039.","journal-title":"Oncol Lett"},{"issue":"11","key":"338_CR27","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/hed.23482","volume":"36","author":"V Murthy","year":"2014","unstructured":"Murthy V, Narang K, Ghosh-Laskar S, Gupta T, Budrukkar A, Agrawal JP. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials. Head Neck. 2014;36(11):1573\u201380. https:\/\/doi.org\/10.1002\/hed.23482.","journal-title":"Head Neck"},{"issue":"1","key":"338_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1748-717X-9-104","volume":"9","author":"Z Akgun","year":"2014","unstructured":"Akgun Z, et al. V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck. Radiat Oncol. 2014;9(1):104. https:\/\/doi.org\/10.1186\/1748-717X-9-104.","journal-title":"Radiat Oncol"},{"issue":"1","key":"338_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jnci.2018.01.004","volume":"30","author":"M El-Shebiney","year":"2018","unstructured":"El-Shebiney M, El-mashad N, El-mashad W, El-Ebiary AA, Kotkat AE. Radiotherapeutic factors affecting the incidence of developing hypothyroidism after radiotherapy for head and neck squamous cell cancer. J Egypt Natl Cancer Inst. 2018;30(1):33\u20138. https:\/\/doi.org\/10.1016\/j.jnci.2018.01.004.","journal-title":"J Egypt Natl Cancer Inst"},{"issue":"1","key":"338_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12885-023-11749-7","volume":"24","author":"C Wang","year":"2024","unstructured":"Wang C, Hou Y, Wang L, Yang Y, Li X. Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors. BMC Cancer. 2024;24(1):5. https:\/\/doi.org\/10.1186\/s12885-023-11749-7.","journal-title":"BMC Cancer"},{"issue":"3","key":"338_CR31","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/j.ijrobp.2012.05.020","volume":"84","author":"MJ Boomsma","year":"2012","unstructured":"Boomsma MJ, et al. A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model. Int J Radiat Oncol. 2012;84(3):e351\u20136. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.05.020.","journal-title":"Int J Radiat Oncol"}],"container-title":["Oncology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-025-00338-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40487-025-00338-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-025-00338-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:13:12Z","timestamp":1748869992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40487-025-00338-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,12]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["338"],"URL":"https:\/\/doi.org\/10.1007\/s40487-025-00338-2","relation":{},"ISSN":["2366-1070","2366-1089"],"issn-type":[{"value":"2366-1070","type":"print"},{"value":"2366-1089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,12]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ahmad Ameri, Zohreh Azma, Khashayar Fattah, Fereshteh Talebi, Pooya Ameri, Nazanin Rahnama, Mansour Lesan, Sanaz Poshtmahi, Farahnaz Rahimi, and Marjan Mirsalehi have nothing to disclose. Farzad Taghizadeh-Hesary is an editorial board member of Oncology and Therapy. Farzad Taghizadeh-Hesary was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The IRB of Shahid Beheshti University of Medical Sciences approved the study protocol (approval ID\u2014IR.SBMU.MSP.REC.1400.198) Owing to the retrospective nature of the study, Shahid Beheshti University of Medical Sciences waived the requirement to obtain informed consent and additional ethical clearance. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}